11794149

Source:http://linkedlifedata.com/resource/pubmed/id/11794149

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0022742, umls-concept:C0205164, umls-concept:C0206460, umls-concept:C0439608, umls-concept:C0543467, umls-concept:C1098510, umls-concept:C1707455, umls-concept:C1708528, umls-concept:C1861172
pubmed:issue	18
pubmed:dateCreated	2001-10-18
pubmed:abstractText	Despite thromboprophylaxis, major knee surgery carries a high risk of venous thromboembolism. Fondaparinux, the first of a new class of synthetic antithrombotic agents, may reduce this risk.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/11794149-11794155, http://linkedlifedata.com/resource/pubmed/commentcorrection/11794149-11934350
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Enoxaparin, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Polysaccharides, http://linkedlifedata.com/resource/pubmed/chemical/fondaparinux
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0028-4793
pubmed:author	pubmed-author:BauerK AKA, pubmed-author:ErikssonB IBI, pubmed-author:LassenM RMR, pubmed-author:Steering Committee of the Pentasaccharide in Major Knee Surgery Study, pubmed-author:TurpieA GAG
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	345
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1305-10
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11794149-Aged, pubmed-meshheading:11794149-Double-Blind Method, pubmed-meshheading:11794149-Drug Administration Schedule, pubmed-meshheading:11794149-Enoxaparin, pubmed-meshheading:11794149-Female, pubmed-meshheading:11794149-Fibrinolytic Agents, pubmed-meshheading:11794149-Hemorrhage, pubmed-meshheading:11794149-Humans, pubmed-meshheading:11794149-Incidence, pubmed-meshheading:11794149-Injections, Subcutaneous, pubmed-meshheading:11794149-Knee, pubmed-meshheading:11794149-Male, pubmed-meshheading:11794149-Polysaccharides, pubmed-meshheading:11794149-Postoperative Complications, pubmed-meshheading:11794149-Pulmonary Embolism, pubmed-meshheading:11794149-Surgical Procedures, Elective, pubmed-meshheading:11794149-Thromboembolism, pubmed-meshheading:11794149-Venous Thrombosis
pubmed:year	2001
pubmed:articleTitle	Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
pubmed:affiliation	Department of Medicine, Veterans Affairs Boston Healthcare System and Beth Israel Deaconess Medical Center, MA 02215, USA. kbauer@caregroup.harvard.edu
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study